Solpadeine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
1998 advertisement

Solpadeine is the brand name of a range of analgesic medication containing various amounts of paracetamol, ibuprofen, caffeine and codeine, currently made by Omega Pharma.[1] The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.[2]

In the United Kingdom there are four different medicines using the Solpadeine name, with no common active ingredient between them. The range includes:

  • Solpadeine Headache, containing paracetamol with caffeine
  • Solpadeine Plus, a compound analgesic containing paracetamol and codeine (co-codamol), with caffeine
  • Solpadeine Max, a compound analgesic containing paracetamol and codeine (with a higher codeine content than Solpadeine Plus), but without the caffeine
  • Solpadeine Migraine, a compound analgesic containing ibuprofen and codeine

In 2016 it was one of the biggest selling branded over-the-counter medications sold in Great Britain, with sales of £43.1 million.[3]

In Australia it is marketed as Panadeine.[4]

External links[edit]

References[edit]

  1. ^ "Omega Pharma - Solpadeine". Omega-pharma.pl. Retrieved 2013-09-14. 
  2. ^ Corporate Comms (2012-03-15). "GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands". Us.gsk.com. Retrieved 2013-09-14. 
  3. ^ "A breakdown of the over-the-counter medicines market in Britain in 2016". Pharmaceutical Journal. 28 April 2017. Retrieved 29 May 2017. 
  4. ^ "Panadeine - GlaxoSmithKline New Zealand". Gsk.co.nz. 2008-11-17. Retrieved 2013-09-14.